Expertise in
3
conditions

Naseem Salahuddin

Plot C-76, Sector 31/5, Korangi Crossing, 
Karachi, SD, PK 
Expertise in
3
conditions
Plot C-76, Sector 31/5, Korangi Crossing, 
Karachi, SD, PK 

Overview

Naseem Salahuddin practices practicing medicine in Karachi, Pakistan.

Salahuddin is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Rabies, Scrofula, Pulmonary Tuberculosis, and Lymphadenitis.

They are actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 2 clinical trials.

Locations

Plot C-76, Sector 31/5, Korangi Crossing, Karachi, SD 75190, Pakistan
Other Locations
Korangi Crossing, Karachi, SD, Pakistan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial
Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial
Enrollment Status: Completed
Publish Date: February 10, 2025
Intervention Type: Drug
Study Drugs: Bedaquiline, Delamanid, Clofazimine, Levofloxacin, Moxifloxacin, Linezolid, Pyrazinamide, MDR-TB regimen
Study Phase: Phase 3
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
Enrollment Status: Completed
Publish Date: February 10, 2025
Intervention Type: Drug
Study Drugs: Bedaquiline, Delamanid, Clofazimine, Linezolid, MDR-TB regimen
Study Phase: Phase 3
View 1 Less Clinical Trial

47 Total Publications

Identification and drug resistance profiling of Mycobacterium orygis from an African elephant using whole-genome sequencing.
Identification and drug resistance profiling of Mycobacterium orygis from an African elephant using whole-genome sequencing.
Journal: Microbiology spectrum
Published: May 07, 2026

Frequently Asked Questions about Naseem Salahuddin

Is Naseem Salahuddin a top-rated expert for Rabies?

MediFind is an objective health platform that identifies experts based on real-world data. Naseem Salahuddin is classified as an Advanced expert for Rabies, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Naseem Salahuddin participate in research or clinical trials?

Yes. Naseem Salahuddin has published 47 articles and abstracts on conditions like Rabies. You can view a list of Naseem Salahuddin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Salahuddin's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile